Sidley Life Sciences Briefing
Switzerland Expands Integrity Rules to Medical Devices: Key Compliance Implications for Medtech Companies
August 2026
Switzerland is preparing to extend its integrity and anti-inducement rules to the medical device sector, significantly expanding compliance obligations for medtech companies operating in the Swiss market. The proposed revision would bring manufacturers, distributors, hospital procurement functions, and healthcare professionals within scope of a stricter regulatory framework governing commercial interactions involving medical devices.
Offices
Related Resources
Related Blogs
Capabilities
Suggested News & Insights
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory


